Log in to save to my catalogue

Connecting genetic risk to disease end points through the human blood plasma proteome

Connecting genetic risk to disease end points through the human blood plasma proteome

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_8795d9d74e404676970c345596c0741f

Connecting genetic risk to disease end points through the human blood plasma proteome

About this item

Full title

Connecting genetic risk to disease end points through the human blood plasma proteome

Publisher

London: Nature Publishing Group UK

Journal title

Nature communications, 2017-02, Vol.8 (1), p.14357-14, Article 14357

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Genome-wide association studies (GWAS) with intermediate phenotypes, like changes in metabolite and protein levels, provide functional evidence to map disease associations and translate them into clinical applications. However, although hundreds of genetic variants have been associated with complex disorders, the underlying molecular pathways often...

Alternative Titles

Full title

Connecting genetic risk to disease end points through the human blood plasma proteome

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_8795d9d74e404676970c345596c0741f

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_8795d9d74e404676970c345596c0741f

Other Identifiers

ISSN

2041-1723

E-ISSN

2041-1723

DOI

10.1038/ncomms14357

How to access this item